ZA862941B - (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)quinolizine,process for its preparation and pharmaceutical compositions containing same - Google Patents

(-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)quinolizine,process for its preparation and pharmaceutical compositions containing same

Info

Publication number
ZA862941B
ZA862941B ZA862941A ZA862941A ZA862941B ZA 862941 B ZA862941 B ZA 862941B ZA 862941 A ZA862941 A ZA 862941A ZA 862941 A ZA862941 A ZA 862941A ZA 862941 B ZA862941 B ZA 862941B
Authority
ZA
South Africa
Prior art keywords
octahydroindolo
1alpha
1beta
quinolizine
hydroxymethyl
Prior art date
Application number
ZA862941A
Other languages
English (en)
Inventor
Csaba Szantay
Lajos Szabo
Gyoergy Kalaus
Zsolt Szombathelyi
Egon Karpati
Bela Kiss
Katalin Csomor
Istvan Laszlovsky
Erzsebet Lapis
Laszlo Szporny
Lilla Forgacs
Csaba Kuthi
Aniko Gere
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ZA862941B publication Critical patent/ZA862941B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
ZA862941A 1985-04-19 1986-04-18 (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)quinolizine,process for its preparation and pharmaceutical compositions containing same ZA862941B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU851519A HU194221B (en) 1985-04-19 1985-04-19 Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound

Publications (1)

Publication Number Publication Date
ZA862941B true ZA862941B (en) 1986-12-30

Family

ID=10954847

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA862941A ZA862941B (en) 1985-04-19 1986-04-18 (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)quinolizine,process for its preparation and pharmaceutical compositions containing same

Country Status (35)

Country Link
US (1) US4806545A (hu)
JP (1) JPH072637B2 (hu)
CN (1) CN1023560C (hu)
AR (1) AR240699A1 (hu)
AT (1) AT390954B (hu)
AU (1) AU591896B2 (hu)
BE (1) BE904588A (hu)
BG (1) BG60433B2 (hu)
CA (1) CA1299574C (hu)
CH (1) CH668262A5 (hu)
CS (1) CS274276B2 (hu)
DD (1) DD244556A5 (hu)
DE (1) DE3613180C2 (hu)
DK (1) DK159780C (hu)
EG (1) EG18059A (hu)
ES (1) ES8706152A1 (hu)
FI (1) FI83870C (hu)
FR (1) FR2580649B1 (hu)
GB (1) GB2174701B (hu)
GR (1) GR861027B (hu)
HU (1) HU194221B (hu)
IE (1) IE59199B1 (hu)
IL (1) IL78538A (hu)
IN (1) IN162810B (hu)
IT (1) IT1204306B (hu)
LU (1) LU86397A1 (hu)
NL (1) NL8600976A (hu)
NO (1) NO167143C (hu)
NZ (1) NZ215879A (hu)
PH (1) PH25316A (hu)
PT (1) PT82424B (hu)
SE (1) SE460196B (hu)
SU (1) SU1438612A3 (hu)
YU (1) YU44286B (hu)
ZA (1) ZA862941B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191454B (en) * 1984-10-05 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt.,Hu Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof
HU207070B (en) * 1990-10-31 1993-03-01 Richter Gedeon Vegyeszet Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
HUP0500201A2 (hu) * 2002-04-03 2005-07-28 Orion Corp. Policiklusos vegyületek, mint potenciális alfa2-adrenoceptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
AU2003235931A1 (en) * 2002-05-13 2003-11-11 Takata Seiyaku Co., Ltd. Vintoperol-containing medicinal composition for transdermal administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170495B (hu) * 1974-05-07 1977-06-28
GB1499546A (en) * 1974-05-07 1978-02-01 Richter Gedeon Vegyeszet Indolo-quinolizidine derivatives and a process for the preparation thereof
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof

Also Published As

Publication number Publication date
DK159780B (da) 1990-12-03
NZ215879A (en) 1989-04-26
PT82424B (pt) 1988-03-03
EG18059A (en) 1991-06-30
JPH072637B2 (ja) 1995-01-18
FI83870B (fi) 1991-05-31
AT390954B (de) 1990-07-25
GB2174701B (en) 1989-02-15
CN1023560C (zh) 1994-01-19
BE904588A (fr) 1986-10-14
CH668262A5 (de) 1988-12-15
CS286386A2 (en) 1990-09-12
DK179786A (da) 1986-10-20
AU5638386A (en) 1986-10-23
FI861641A (fi) 1986-10-20
DK159780C (da) 1991-04-22
HUT40433A (en) 1986-12-28
BG60433B2 (bg) 1995-03-31
SE8601799D0 (sv) 1986-04-18
DD244556A5 (de) 1987-04-08
GB2174701A (en) 1986-11-12
FR2580649B1 (fr) 1991-03-29
CN86102479A (zh) 1986-10-22
FI861641A0 (fi) 1986-04-18
LU86397A1 (hu) 1986-09-02
IL78538A (en) 1989-10-31
YU44286B (en) 1990-04-30
YU62486A (en) 1988-06-30
IE861033L (en) 1986-10-19
SE8601799L (sv) 1986-10-20
DK179786D0 (da) 1986-04-18
CS274276B2 (en) 1991-04-11
IT1204306B (it) 1989-03-01
JPS61249986A (ja) 1986-11-07
AR240699A1 (es) 1990-09-28
GB8609533D0 (en) 1986-05-21
IT8620136A0 (it) 1986-04-18
DE3613180A1 (de) 1986-10-23
NO167143B (no) 1991-07-01
DE3613180C2 (de) 1995-10-19
ES8706152A1 (es) 1987-06-01
PT82424A (en) 1986-05-01
NL8600976A (nl) 1986-11-17
FR2580649A1 (fr) 1986-10-24
AU591896B2 (en) 1989-12-21
IN162810B (hu) 1988-07-09
US4806545A (en) 1989-02-21
IL78538A0 (en) 1986-08-31
SE460196B (sv) 1989-09-18
HU194221B (en) 1988-01-28
NO861539L (no) 1986-10-20
PH25316A (en) 1991-04-30
ES554143A0 (es) 1987-06-01
FI83870C (fi) 1991-09-10
SU1438612A3 (ru) 1988-11-15
GR861027B (en) 1986-08-12
IE59199B1 (en) 1994-01-26
NO167143C (no) 1991-10-09
ATA102986A (de) 1990-01-15
CA1299574C (en) 1992-04-28

Similar Documents

Publication Publication Date Title
IL81833A0 (en) Renin inhibitors,their preparation and pharmaceutical compositions containing them
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
IL93136A0 (en) Tetrahydroimidazo(1,4)benzodiazepin-2-thione derivatives,their preparation and pharmaceutical compositions containing them
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
IL80394A0 (en) Antihypertensive thieno-isoxazoles and thieno-pyrazoles,process for their preparation and pharmaceutical compositions containing them
ZA853667B (en) New benzazephine derivatives,pharmaceutical compositions containing them and processes for their preparation
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
IL80658A0 (en) 6,7,8,9-tetrahydro-10-methyl-pyrido(1,2-a)indol-9-amines and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL85840A (en) Substituted 2-phenylimidazo(1,2-a)pyridine-3-acetamides and pharmaceutical compositions containing them
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
ZA862941B (en) (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)quinolizine,process for its preparation and pharmaceutical compositions containing same
DE3573428D1 (en) Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
EP0184841A3 (en) 1,4-dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing same
ZA862943B (en) 12b-substituted 1-hydroxymethyl-octahydroindolo-(2,3-a)quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
ZA862942B (en) 1,12b-disubstituted octahydroindolo(2,3-a)-quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them
IL88658A0 (en) 8,9-annelated beta-carbolines and 3,4-dihydro-beta-carbolines,their preparation and pharmaceutical compositions containing them
EP0301245A3 (en) 3-sulfonyl-3,7-diazabicyclo-(3,3,1)nonane compounds, processes for their preparation, and medicaments containing these compounds
DE3574381D1 (en) Xanthinylmethylthiazolidines, process for their preparation and pharmaceutical compositions containing them
IL64328A (en) 2,3,3a,4,5,6-hexahydro-1h-indolo(3,2,1-de)(1,5-naphthyridine)derivatives,their preparation and pharmaceutical compositions containing them
ZA889129B (en) Dipeptide compounds,processes for their preparation and compositions containing them
IL80435A (en) 5-r-(het)-2,4-dialkyl-3h-1,2,4-triazole-3-thiones,process for their preparation and pharmaceutical compositions containing same
ZA865973B (en) Cephalosprin derivatives,process for their preparation and pharmaceutical compositions containing them
GR860757B (en) Substituted 1,8-naphthyridinones processes for their preparation and pharmaceutical compositions containing them
NZ209020A (en) 1,6 -naphthyridine derivatives and pharmaceutical compositions containing such